Wilson Kemp & Associates’s AbbVie ABBV Stock Holding History

Wilson Kemp & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,867	Closed	-$331K	–	28
2014 Q2	$331K	Sell	5,867 -400	-6%	-$21K	1.19%	36
2014 Q1	$322K	Sell	6,267 -2,900	-32%	-$147K	0.84%	40
2013 Q4	$484K	Buy	9,167 +150	+2%	+$7.37K	0.93%	38
2013 Q3	$403K	Sell	9,017 -1,925	-18%	-$85.3K	0.89%	39
2013 Q2	$452K	Buy	+10,942	New	+$479K	0.43%	60

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wilson Kemp & Associates's ABBV Position: Q3 2014 in Review

Wilson Kemp & Associates sold out of AbbVie (ABBV) in Q3 2014, closing a stake of 5,867 shares — an estimated $331K sold.

Wilson Kemp & Associates first reported a position in ABBV in Q2 2013 and held it in 5 quarters. The position peaked at $484K in Q4 2013. 1,503 funds tracked by Wall St. Rank hold ABBV as of Q3 2014.

Wilson Kemp & Associates reported no remaining AbbVie position as of Q3 2014 after selling out during the quarter.
Wilson Kemp & Associates sold 5,867 AbbVie shares in Q3 2014, an estimated $331K.
Wilson Kemp & Associates first reported a position in AbbVie in Q2 2013 and held it in 5 quarters.
Wilson Kemp & Associates's AbbVie position peaked at $484K in Q4 2013.
1,503 funds tracked by Wall St. Rank held AbbVie as of Q3 2014.

Based on Wilson Kemp & Associates's 13F filing for Q3 2014, filed 20 Oct 2014.